Biovac
Chemicals & Related Products · South Africa · 201-500 Employees
View Company Info for Free
Overview
Headquarters
15 Alexandra Ndabeni Rd, Cape Town, 7405...Phone Number
+27 215145000Website
www.biovac.co.zaRevenue
$150.7 MillionIndustry
About Biovac
Biovac Org Chart
Is Biovac your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Biovac launches new products
Earning: See what the market has to say on Biovac recently announced quarterly report
Biovac, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biovac is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Biovac
Click to see if Biovac had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Biovac has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Biovac has new funding data
Recommended Actions
Reach out to Masked Content who joined Biovac as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Biovac is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biovac is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biovac.
Biovac financials insights
Gather financial insights about Biovac, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$108.3M
Biovac Tech Stack
A closer look at the technologies used by Biovac
Most Recent Scoops
Biovac News & Media
South Africa's Biovac in new oral cholera vaccine deal - Reuters
South Africa's Biovac Institute has signed a licensing and technology transfer deal with the International Vaccine Institute (IVI) to develop and make oral cholera vaccine for African and global markets, the companies said on Wednesday.Pfizer/BioNTech strike South Africa COVID-19 manufacturing deal with Biovac
Pfizer Inc (PFE.N) and BioNTech SE on Wednesday said they had struck a deal for South Africa's Biovac Institute to process and distribute over 100 million doses a year of their COVID-19 vaccine for the African Union beginning in 2022.Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac,” a Cape Town-based, South African biopharmaceutical company, to manufacture the Pfizer-BioNTech COVID-19 Vaccine for distribution within the African Union. Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufLive updates: SA secures more jabs, AstraZeneca vaccine SLASHES transmission
As the vaccine rollout begins in South Africa, we are publishing all the latest updates related to the biggest immunisation drive in our history.
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biovac
Biovac is a biopharmaceutical company focused on the development, manufacture, and supply of vaccines and biological products. Established through a public-private partnership, it works to strengthen local vaccine production capabilities and support national healthcare systems. The company collaborates with global partners to introduce advanced tec... Read More


